Everyone expressing an interest in taking part in the large phase 3 ASPro-PD ambroxol trial will be genetically screened, via PD Frontline, as part of the trial selection criteria. PD Frontline are currently prioritising people under the age of 75 who have been diagnosed with Parkinson’s within the last six years.

Ambroxol and Parkinson’s – find out more here

Registration of interest form:

We also ask you to complete the form below to register your interest with us. This will help you stay up-to-date with Cure Parkinson’s research and fundraising news and direct you on to PD Frontline.

The ASPro-PD study team have been busy with aspects of the trial start-up process. The trial manager has been employed and key documents required for the submission to the ethics committee and the regulatory bodies are being finalised. In preparation for this large phase 3 study, the team are working with a number of research centres around the country in readiness for the trial participants. In our ongoing commitment to keeping you informed, we will release quarterly updates on the project for those who have registered their interest with us. Our next update will be in May unless we have additional news to share before then. We remain committed to seeing ambroxol tested further in Parkinson’s.

If you have not already done so, please register your interest using the form below. Please also note that PD Frontline will be prioritising people under the age of 75 who have been diagnosed with Parkinson’s in the last 6 years for genetic screening. If you have any specific questions or concerns, please contact our Recruitment and Retention Officer, Anaya.

Email Anaya